Back
Aquestive Therapeutics, Inc. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
54
AQST
Aquestive Therapeutics, Inc.
Last Price:
$6.45
Seasonality Move:
-26.01%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAquestive Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Aquestive Therapeutics, Inc. has on average historically risen by 22.2% based on the past 7 years of stock performance.
-
Aquestive Therapeutics, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is Aquestive Therapeutics, Inc. Stock Undervalued?The current Aquestive Therapeutics, Inc. [AQST] share price is $6.44. The Score for AQST is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
AQST is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Aquestive Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Aquestive Therapeutics, Inc. has on average historically risen by 22.2% based on the past 7 years of stock performance.
Aquestive Therapeutics, Inc. Stock Rating
Buy
54
Aquestive Therapeutics, Inc. (AQST)
is a Buy
Is Aquestive Therapeutics, Inc. overpriced?
-
Aquestive Therapeutics, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Aquestive Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
aquestive.com
52-Week Data
52-Week High:
7.55
52-Week Low:
2.12
Prediction Charts
Market Cap:
785.7M
Price in USD:
6.44
Volume:
2.3M
Beta:
2.66
Technical Analysis
SMA50:
6.23
SMA100:
5.27
SMA200:
4.12
52-Wk Change:
49.42%
Stock Predictions
-
Is Aquestive Therapeutics, Inc. stock public?Yes, Aquestive Therapeutics, Inc. is a publicly traded company.
-
What is the Aquestive Therapeutics, Inc. stock quote today?The Aquestive Therapeutics, Inc. stock price is 6.44 USD today.
-
How to buy Aquestive Therapeutics, Inc. stock online?You can buy Aquestive Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 5.24 | 5.39 | 5.51 | 5.21 |
| Nov-17 | 5.39 | 5.82 | 5.83 | 5.35 |
| Nov-18 | 5.77 | 5.91 | 5.95 | 5.68 |
| Nov-19 | 5.95 | 5.83 | 6.15 | 5.65 |
| Nov-20 | 5.84 | 5.62 | 6.17 | 5.54 |
| Nov-21 | 5.54 | 5.72 | 5.79 | 5.53 |
| Nov-24 | 5.80 | 5.78 | 5.94 | 5.76 |
| Nov-25 | 5.80 | 6.09 | 6.13 | 5.73 |
| Nov-26 | 6.15 | 6.22 | 6.29 | 5.89 |
| Nov-28 | 6.28 | 6.19 | 6.40 | 6.18 |
| Dec-1 | 6.10 | 6.20 | 6.27 | 6.02 |
| Dec-2 | 6.22 | 5.93 | 6.34 | 5.92 |
| Dec-3 | 5.98 | 6.15 | 6.22 | 5.90 |
| Dec-4 | 6.20 | 6.44 | 6.55 | 6.13 |
Aquestive Therapeutics, Inc. Earnings
Aquestive Therapeutics, Inc. Earnings Report: Per Share Aquestive Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Aquestive Therapeutics, Inc. Forecast Revenue Growth
Aquestive Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Aquestive Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $0.13 per share.
* Aquestive Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.